Hillstream BioPharma Inc. (HILS)
NASDAQ: HILS
· Real-Time Price · USD
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 9:59 PM
Hillstream BioPharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.85M | -2.36M | -2.71M | -1.77M | -2.13M | -1.64M | -1.35M | -101.59K | -541.11K | -1.1M | -1.47M |
Interest Income | 28.45K | 34.2K | 32.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.82M | -2.34M | -2.69M | -1.77M | -2.13M | -1.64M | -2.94M | 2.45M | -853.44K | -1.56M | -2.25M |
Net Income | -1.82M | -2.34M | -2.67M | -1.6B | -2.13M | -1.64M | -2.94M | 2.45M | -853.44K | -1.56M | -2.25M |
Selling & General & Admin | 1.36M | 1.33M | 1.67M | 1.08M | 1.3M | 1.18M | 1.04M | 142.6K | 227.98K | 422.95K | 571.68K |
Research & Development | 488.18K | 1.03M | 1.05M | 683.21K | 831.84K | 455.55K | 307.83K | -41.01K | 313.13K | 674.76K | 895.91K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.81M | -76.5K | -269.47K | -634.27K |
Operating Expenses | 1.85M | 2.36M | 2.71M | 1.77M | 2.13M | 1.64M | 1.35M | 101.59K | 541.11K | 1.1M | 1.47M |
Interest Expense | 3.5K | 6.52K | 6.14K | n/a | n/a | n/a | 1.59M | 258.37K | 235.82K | 188.9K | 148.19K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.85M | 2.36M | 2.71M | 1.77M | 2.13M | 1.64M | 1.35M | 101.59K | 541.11K | 1.1M | 1.47M |
Income Tax Expense | n/a | n/a | -19.97K | 1.59B | n/a | n/a | n/a | 258.37K | 235.82K | 188.9K | 148.19K |
Shares Outstanding (Basic) | 17.29M | 14.95M | 11.51M | 11.23M | 11.53M | 11.57M | 10.57M | 10.3M | 10.3M | 11.23M | 11.23M |
Shares Outstanding (Diluted) | 17.29M | 14.95M | 11.51M | 11.23M | 11.53M | 11.57M | 10.57M | 10.3M | 10.3M | 11.23M | 11.23M |
EPS (Basic) | -0.11 | -0.16 | -0.23 | -142.1 | -0.18 | -0.14 | -0.28 | 0.24 | -0.08 | -0.14 | -0.2 |
EPS (Diluted) | -0.11 | -0.16 | -0.23 | -142.1 | -0.18 | -0.14 | -0.28 | 0.24 | -0.08 | -0.14 | -0.2 |
EBITDA | -1.82M | -2.33M | -2.68M | -1.77M | -2.13M | -1.64M | -1.35M | 2.71M | -617.61K | -1.37M | -2.1M |
EBIT | -1.82M | -2.33M | -2.68M | -10.06B | n/a | n/a | n/a | -496.71K | -381.79K | -1.18M | -1.95M |
Depreciation & Amortization | 28.45K | 34.2K | 32.25K | -1.57M | 27.08K | 86.06K | 60.46K | 2.81M | -76.5K | -269.47K | -634.27K |